Vericel Backtesting

Vericel Corporation -- USA Stock  

USD 4.73  0.02  0.42%

With this equity back-testing module your can estimate the performance of a buy and hold strategy of Vericel Corporation and determine expected loss or profit from investing in Vericel over given investment horizon. Also please take a look at Vericel Hype Analysis, Vericel Correlation, Vericel Valuation, Vericel Volatility as well as analyze Vericel Alpha and Beta and Vericel Performance
Investment Horizon     30 Days    Login   to change

Vericel 'What if' Analysis

November 13, 2017
No Change 0.00  0.0%
In 30 days
December 13, 2017
If you would invest  0.00  in Vericel on November 13, 2017 and sell it all today you would earn a total of 0.00 from holding Vericel Corporation or generate 0.0% return on investment in Vericel over 30 days. Vericel is related to or competes with NantKwest. It markets two autologous cell therapy products including Carticel an autologous chondrocyte implant for the treatment o...

Vericel Upside/Downside Indicators


Vericel Market Premium Indicators

Vericel lagged returns against current returns

 Current and Lagged Values 

Vericel regressed lagged prices vs. current prices

 Current vs Lagged Prices 

Vericel Backtested Returns

Vericel is unusually risky given 1 month investment horizon. Vericel owns Efficiency Ratio (i.e. Sharpe Ratio) of 0.2366 which indicates Vericel had 0.2366% of return per unit of risk over the last 1 month. Our philosophy towards measuring risk of a stock is to use both market data as well as company specific technical data. We found twenty-one different technical indicators which can help you to evaluate if expected returns of 1.0302% are justified by taking the suggested risk. Use Vericel Semi Deviation of 2.7, Coefficient Of Variation of 535.96 and Risk Adjusted Performance of 0.1012 to evaluate company specific risk that cannot be diversified away. Vericel holds performance score of 15 on a scale of zero to a hundred. The entity has beta of 2.906 which indicates as market goes up, the company is expected to significantly outperform it. However, if the market returns are negative, Vericel will likely underperform.. Although it is vital to follow to Vericel current price movements, it is good to be conservative about what you can actually do with the information regarding equity historical returns. Macroaxis philosophy towards measuring future performance of any stock is to look not only at its past charts but also at the business as a whole, including all fundamental and technical indicators. To evaluate if Vericel Corporation expected return of 1.0302 will be sustainable into the future, we have found twenty-one different technical indicators which can help you to check if the expected returns are sustainable. Use Vericel Jensen Alpha, Potential Upside as well as the relationship between Potential Upside and Skewness to analyze future returns on Vericel.
Advice Volatility Trend Exposure Correlations
15 days auto-correlation 0.54 

Modest predictability

Vericel Corporation has modest predictability. Overlapping area represents the amount of predictability between Vericel time series from November 13, 2017 to November 28, 2017 and November 28, 2017 to December 13, 2017. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Vericel price movement. The serial correlation of 0.54 indicates that about 54.0% of current Vericel price fluctuation can be explain by its past prices.
Correlation Coefficient 0.54
Spearman Rank Test 0.27
Price Variance 0.11
Lagged Price Variance 0.06

Vericel Lagged Returns

 Regressed Prices 

Vericel Performance vs DOW

The median price of Vericel for the period between Mon, Nov 13, 2017 and Wed, Dec 13, 2017 is 4.3 with a coefficient of variation of 10.53. The daily time series for the period is distributed with a sample standard deviation of 0.46, arithmetic mean of 4.33, and mean deviation of 0.39. The Stock received some media coverage during the period.
Price Growth (%)  
Checking the Overall Picture for Vericel Corporation12/08/2017